1. Home
  2. UAN vs STAA Comparison

UAN vs STAA Comparison

Compare UAN & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CVR Partners LP

UAN

CVR Partners LP

HOLD

Current Price

$135.38

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo STAAR Surgical Company

STAA

STAAR Surgical Company

HOLD

Current Price

$22.65

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UAN
STAA
Founded
2007
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Ophthalmic Goods
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2008
1995

Fundamental Metrics

Financial Performance
Metric
UAN
STAA
Price
$135.38
$22.65
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$22.81
AVG Volume (30 Days)
29.6K
874.6K
Earning Date
04-29-2026
05-12-2026
Dividend Yield
7.91%
N/A
EPS Growth
61.98
N/A
EPS
12.06
0.26
Revenue
$606,038,000.00
$239,442,000.00
Revenue This Year
N/A
$30.82
Revenue Next Year
N/A
$8.41
P/E Ratio
$11.04
$90.85
Revenue Growth
15.36
N/A
52 Week Low
$86.43
$15.59
52 Week High
$139.50
$35.87

Technical Indicators

Market Signals
Indicator
UAN
STAA
Relative Strength Index (RSI) 69.00 47.81
Support Level $120.76 $23.27
Resistance Level $139.42 $24.26
Average True Range (ATR) 2.55 0.82
MACD 0.76 0.17
Stochastic Oscillator 92.51 70.13

Price Performance

Historical Comparison
UAN
STAA

About UAN CVR Partners LP

CVR Partners LP is a manufacturer and supplier of nitrogen fertilizer products. Its principal products include Urea Ammonium Nitrate (UAN) and ammonia. The company market ammonia products to industrial and agricultural customers and UAN products to agricultural customers. The primary geographic markets for its fertilizer products are Kansas, Missouri, Nebraska, Iowa, Illinois, Colorado, and Texas. The company's product sales are heavily weighted toward UAN.

About STAA STAAR Surgical Company

Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.

Share on Social Networks: